BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14744278)

  • 21. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage.
    Etminan N; Beseoglu K; Eicker SO; Turowski B; Steiger HJ; Hänggi D
    Stroke; 2013 Aug; 44(8):2162-8. PubMed ID: 23735957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.
    Seifert V; Eisert WG; Stolke D; Goetz C
    Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
    Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature.
    Velat GJ; Kimball MM; Mocco JD; Hoh BL
    World Neurosurg; 2011 Nov; 76(5):446-54. PubMed ID: 22152574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
    Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous Hydrogen Therapy With Intracisternal Magnesium Sulfate Infusion in Severe Aneurysmal Subarachnoid Hemorrhage.
    Takeuchi S; Kumagai K; Toyooka T; Otani N; Wada K; Mori K
    Stroke; 2021 Jan; 52(1):20-27. PubMed ID: 33349011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study.
    Egge A; Waterloo K; Sjøholm H; Solberg T; Ingebrigtsen T; Romner B
    Neurosurgery; 2001 Sep; 49(3):593-605; discussion 605-6. PubMed ID: 11523669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage.
    Steinberg GK; Vanefsky MA; Marks MP; Adler JR; Koenig GH
    Neurosurgery; 1994 May; 34(5):809-13; discussion 813-4. PubMed ID: 8052377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing subarachnoid fibrinolytic therapy for aneurysmal subarachnoid hemorrhage.
    Macdonald RL
    World Neurosurg; 2010 Jun; 73(6):622-3. PubMed ID: 20934139
    [No Abstract]   [Full Text] [Related]  

  • 31. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol-Reducing Agents for Treatment of Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Akhigbe T; Zolnourian A; Bulters D
    World Neurosurg; 2017 May; 101():476-485. PubMed ID: 28192263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Statins on Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.
    Zhang BF; Song JN; Wang J; Ma XD; Zhang ST; Zhao JJ; Shu K; Sun P; Zhao YL
    Turk Neurosurg; 2015; 25(6):850-7. PubMed ID: 26617132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous magnesium therapy in adult patients with an aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis.
    Yarad EA; Hammond NE
    Aust Crit Care; 2013 Aug; 26(3):105-17. PubMed ID: 23806874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial.
    Zwienenberg-Lee M; Hartman J; Rudisill N; Madden LK; Smith K; Eskridge J; Newell D; Verweij B; Bullock MR; Baker A; Coplin W; Mericle R; Dai J; Rocke D; Muizelaar JP;
    Stroke; 2008 Jun; 39(6):1759-65. PubMed ID: 18420953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.
    Kramer AH; Gurka MJ; Nathan B; Dumont AS; Kassell NF; Bleck TP
    Neurosurgery; 2008 Feb; 62(2):422-7; discussion 427-30. PubMed ID: 18382320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model.
    Hariton GB; Findlay JM; Weir BK; Kasuya H; Grace MG; Mielke BW
    Neurosurgery; 1993 Oct; 33(4):691-6; discussion 696-7. PubMed ID: 8232810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
    Westermaier T; Stetter C; Vince GH; Pham M; Tejon JP; Eriskat J; Kunze E; Matthies C; Ernestus RI; Solymosi L; Roosen K
    Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.